Robert J Cherney

This inventor holds 41 USPTO granted patents and 2 published patent applications and 17 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb Pharma Company, The Dupont Merck Pharmaceutical Company. Active years: 1994-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert J Cherney. Retrieved from https://idiyas.com/inventor/robert-j-cherney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 41 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 17 (Patent Applications = 15)

Average Co-Inventor Count = 2.6

ph-index = 8

Forward Citations = 198(Granted Patents)

Location History:

Newark, DE (US) (1994 - 2010)
Princeton, NJ (US) (2014)
Newton, PA (US) (2019)
Newtown, PA (US) (2007 - 2022)

Company Filing History:

29 out of 3,745

Bristol-Myers Squibb Compnay

patents

6 out of 234

Bristol-Myers Squibb Pharma Company

patents

5 out of 206

The Dupont Merck Pharmaceutical Company

patents

4. 1 out of 1

Bristol-Myers Squibb Pharmaceutical Company

patent

5. 1 out of 106

Dupont Pharmaceuticals Company

patents

where one patent can have more than one assignee

Years Active: 1994-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Chemokine Receptor Modulators

Metalloprotease Inhibitors

ROR Gamma Modulators

PI3K Inhibitors

Anticancer Agents

Tricyclic Sulfones

Polycyclic Chromophores

Cyclic Derivatives

Azaindole Inhibitors

S1P1 Agonists

Pyrrolotriazine Compounds

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760029 - KRAS G12D inhibitors (2026-10-13),

2. 12473304 - Heterocyclic PAD4 inhibitors (2025-11-18),

3. 11524959 - Indole and azaindole inhibitors of pad enzymes (2022-12-13),

4. 10934286 - Heterocyclic sulfones as ROR gamma modulators (2021-03-02),

5. 10711020 - Tricyclic sulfones as RORγ modulators (2020-07-14),

6. 10273259 - Tricyclic sulfones as RORγ modulators (2019-04-30),

7. 10214537 - Bicyclic heteroaryl amine compounds (2019-02-26),

8. 10023576 - Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors (2018-07-17),

9. 9815859 - Tricyclic sulfones as RORγ modulators (2017-11-14),

10. 9216972 - Tricyclic heterocyclic compounds (2015-12-22),

11. 8906920 - N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes (2014-12-09),

12. 8835470 - Mandelamide heterocyclic compounds (2014-09-16),

13. 8642622 - Piperidinyl compound as a modulator of chemokine receptor activity (2014-02-04),

14. 8629282 - Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases (2014-01-14),

15. 8618101 - [object Object] (2013-12-31),

Title: The Inventor Profile of Robert J Cherney

Introduction: Robert J Cherney is a distinguished inventor based in Newtown, Pennsylvania, known for his groundbreaking contributions to various fields.

Latest Patents: Robert J Cherney holds several patents in the areas of technology and engineering, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: Throughout his career, Robert J Cherney has demonstrated a keen interest in developing cutting-edge solutions, leading to the successful commercialization of several inventions.

Collaborations: Robert J Cherney has collaborated with leading research institutions and companies to bring his ideas to life, highlighting his ability to work effectively in multidisciplinary teams.

Conclusion: In conclusion, Robert J Cherney's passion for innovation and his dedication to pushing the boundaries of technology make him a prominent figure in the world of inventors.

Profile summary based on public USPTO records.